Cardiopulmonary Stress Testing Systems Market Outlook:
Cardiopulmonary Stress Testing Systems Market size was valued at USD 6.6 billion in 2025 and is set to exceed USD 11.17 billion by 2035, expanding at over 5.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cardiopulmonary stress testing systems is estimated at USD 6.92 billion.
The growth of the market may be further stimulated by rising research and development studies that demonstrate the effectiveness of cardiopulmonary stress tests in detecting cardiac conditions. For example, a study published in May 2022 by the National Institute of Health suggested that selected parameters of the cardiopulmonary exercise test were related to the severity of angina symptoms and quality of life.
The severity of myocardial ischemia is detected by the oxygen pulse plateau. Thus, the benefit of early diagnosis of heart diseases with stress tests may aid in lowering the mortality rate associated with these diseases, as a result fuelling the market expansion.
Due to the increasing incidence of cardiac problems, the market for cardiopulmonary stress testing systems is expected to increase. To reduce hospital stays and decrease mortality, it is necessary to detect CVDs before they occur. To identify and assess the severity of cardiovascular disease, physicians advise using a cardiopulmonary stress test.
The market for cardiopulmonary stress testing systems is expanding as more and more people are using the test equipment to assess their cardiac function. To determine their ability to adapt to the hemodynamic demands of exercise, adult patients with CHD undergo cardiopulmonary exercise tests.
